Arkema announced that they have successfully secured subscription commitments totaling USD 7.5  million through a private investment in a public equity (PIPE) transaction.

Belgium (June 2023):  Biotalysm NV, a Belgian agricultural technology company, has raised USD 7.5 million via private investment in public equity (PIPE) transaction. The investment was led by existing investors Agri Investment Fund BV (“AIF”) and the Belgian Sovereign Wealth Fund Federale Participatie- en Investeringsmaatschappij NV (“SFPIM”). The transaction involved the issuance of 1,135,257 new shares (approximately 3.67% of the outstanding shares of the company before the transaction) at USD 6.65 each, compared to Biotalys shares published on Euronext Brussels on Tuesday, June 6, 2023. The new shares will be listed on Euronext Brussels on 15 June 2023 with the same rights and benefits as existing and outstanding shares of Biotalys at the moment of their issuance.

The proceeds from the PIPE will be used to support Biotalys' growth initiatives, including the development and commercialization of its protein-based biocontrol products. Biotalys' biocontrol products are designed to provide farmers with a more sustainable and environmentally friendly alternative to traditional chemical pesticides.

Biotalys is a leading developer of protein-based biocontrol products for crop protection. The company's products are based on proprietary technology that uses proteins to control pests and diseases. Biotalys' products are designed to be more environmentally friendly and sustainable than traditional chemical pesticides. The company has a strong pipeline of products in development, and it is well-positioned to capitalize on the growing demand for sustainable and environmentally friendly crop protection solutions. Biotalys' products have the potential to make a significant impact on the agricultural industry, and the company is well-funded to execute its growth plans.

With this investment, Biotalys is well-positioned to continue its growth and beco`me a leading player in the agricultural technology industry. The company's protein-based biocontrol products have the potential to revolutionize the way that farmers protect their crops, and Biotalys is well-positioned to capitalize on this opportunity.

According to Patrik Haesen, CEO of Agri Investment Fund BV (“AIF”), “We strongly believe that farmers in Belgium and around the world require new tools to protect their yields while reducing the impact on the environment. We have supported Biotalys since its inception and today want to further build our position as a committed partner with a long-term vision, who can provide financial support as well as a large network and professional advice on various agricultural sectors." Further, Patrice Sellès, Biotalys CEO commented: "After validating our approach with multiple collaborations, including through the recent strategic partnership with Syngenta, we welcome the additional support of current shareholders, bringing us another step closer to our ultimate goal of providing growers all over the world, and particularly in our home country Belgium, with innovative and cost-efficient solutions.”

According to TechSci Research, Biotalysm NV, a biotechnology company developing biological alternatives to synthetic pesticides, has raised USD 7.5 million in a private investment round. The proceeds from the round will support Biotalysm for its product research and development, as well as its commercialization plans. Biotalysm is developing a portfolio of biological products that can be used to control pests and diseases in crops. The company's products are based on a technology platform that uses plant-derived enzymes to target specific pests and diseases.

The investment in Biotalysm is a sign of the growing interest in biological pesticides. The company's technology platform has the potential to revolutionize the way that pests and diseases are controlled in crops. Biotalysm is well-positioned to capitalize on the growth of the biological pesticides market.

Some potential impacts of Biotalysm's private investment round on the market are:

Increased competition in the biological pesticides market. The investment will help Biotalysm to accelerate its research and development efforts and to bring its products to market more quickly. This will increase competition in the biological pesticides market, which will benefit farmers and consumers by driving down prices and improving the availability of biological pesticides.

Increased innovation in the biological pesticides market. The investment will help Biotalysm to continue to develop new and innovative biological pesticides. This will benefit farmers and consumers by providing them with more effective and environmentally friendly ways to control pests and diseases.

Increased awareness of biological pesticides: The investment will help Biotalysm to raise awareness of biological pesticides among farmers, consumers, and policymakers. This will help to promote the use of biological pesticides, which will benefit the environment and human health.

Expansion and growth opportunities: The funds raised can be used to fuel the company's expansion plans, invest in research and development, expand production capacity, or enter new markets. This could potentially lead to increased revenue and market share for the company.